Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes Guest UserJanuary 5, 2023
Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer Guest UserDecember 1, 2022
Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET Guest UserOctober 19, 2022
Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry Guest UserSeptember 21, 2022
Digital Medicine Leader Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I Guest UserAugust 19, 2022
The Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients With SLE Guest UserJuly 14, 2022
Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer Guest UserJune 6, 2022
Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox Guest UserMay 26, 2022
American Journal of Psychiatry Publishes Data Demonstrating Akili's Digital Therapeutic AKL-T03 Improves Cognition in Adults with Major Depressive Disorder When Combined with Antidepressant Medication Guest UserApril 12, 2022
Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day Summit Guest UserApril 4, 2022
Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product Officer Guest UserMarch 17, 2022
Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital Therapeutics Guest UserMarch 10, 2022
Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022 Guest UserMarch 8, 2022
Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022 Guest UserFebruary 18, 2022
PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx ® Activates Systems in Brain Key to Attentional Functioning Guest UserFebruary 17, 2022
Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I Guest UserFebruary 14, 2022
